Literature DB >> 27499969

The value of esophagectomy surgical apgar score (eSAS) in predicting the risk of major morbidity after open esophagectomy.

Xue-Zhong Xing1, Hai-Jun Wang1, Shi-Ning Qu1, Chu-Lin Huang1, Hao Zhang1, Hao Wang1, Quan-Hui Yang1, Yong Gao1.   

Abstract

BACKGROUND: Recently, surgical apgar score (SAS) has been reported to be strongly associated with major morbidity after major abdominal surgery. The aim of this study was to assess the value of esophagectomy SAS (eSAS) in predicting the risk of major morbidity after open esophagectomy in a high volume cancer center.
METHODS: The data of all patients who admitted to intensive care unit (ICU) after open esophagectomy at Cancer Hospital of Chinese Academy of Medical Sciences & Peking Union Medical College from September 2008 through August 2010 was retrospectively collected and reviewed. Preoperative and perioperative variables were recorded and compared. The eSAS was calculated as the sum of the points of EBL, lowest MAP and lowest HR for each patient. Patients were divided into high-risk (below the cutoff) and low-risk (above the cutoff) eSAS groups according to the cutoff score with optimal accuracy of eSAS for major morbidity. Univariable and multivariable regression analysis were used to define risk factors of the occurrence of major morbidity.
RESULTS: Of 189 patients, 110 patients developed major morbidities (58.2%) and 30-day operative mortality was 5.8% (11/189). There were 156 high risk patients (eSAS ≤7) and 33 low risk (eSAS >7) patients. Univariable analysis demonstrated that forced expiratory volume in one second of predicted (FEV1%) ≤78% (44% vs. 61%, P=0.024), McKeown approach (22.7% vs. 7.6%, P=0.011), duration of operation longer than 230 minutes, intraoperative estimated blood loss (347±263 vs. 500±510 mL, P=0.015) and eSAS ≤7 (62.2% vs. 90.0%, P=0.001) were predictive of major morbidity. Multivariable analysis demonstrated that FEV1% ≤78% (OR, 2.493; 95% CI, 1.279-4.858, P=0.007) and eSAS ≤7 (OR, 2.810; 95% CI, 1.105-7.144; P=0.030) were independent predictors of major morbidity after esophagectomy. Compared with patients who had eSAS >7, patients who had eSAS ≤7 had longer hospital length of stay (25.39±14.36 vs. 32.22±22.66 days, P=0.030). However, there were no significant differences in ICU length of stay, duration of mechanical ventilation, ICU death, 30-day death rate and in-hospital death rate between high risk and low risk patients.
CONCLUSIONS: The eSAS score is predictive of major morbidity, and lower eSAS is associated with longer hospital length of stay in esophageal cancer patients after open esophagectomy.

Entities:  

Keywords:  Esophagectomy; esophageal cancer; esophagectomy surgical apgar score (eSAS); major morbidity

Year:  2016        PMID: 27499969      PMCID: PMC4958794          DOI: 10.21037/jtd.2016.06.28

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  27 in total

1.  Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction.

Authors:  Francesco Palazzo; Ernest L Rosato; Asadulla Chaudhary; Nathaniel R Evans; Jocelyn A Sendecki; Scott Keith; Karen A Chojnacki; Charles J Yeo; Adam C Berger
Journal:  J Am Coll Surg       Date:  2014-12-27       Impact factor: 6.113

2.  An Apgar score for surgery.

Authors:  Atul A Gawande; Mary R Kwaan; Scott E Regenbogen; Stuart A Lipsitz; Michael J Zinner
Journal:  J Am Coll Surg       Date:  2006-12-27       Impact factor: 6.113

Review 3.  Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

Authors:  Ulrich Ronellenfitsch; Matthias Schwarzbach; Ralf Hofheinz; Peter Kienle; Meinhard Kieser; Tracy E Slanger; Bryan Burmeister; David Kelsen; Donna Niedzwiecki; Christoph Schuhmacher; Susan Urba; Cornelis van de Velde; Thomas N Walsh; Marc Ychou; Katrin Jensen
Journal:  Eur J Cancer       Date:  2013-06-22       Impact factor: 9.162

4.  Systematic classification of morbidity and mortality after thoracic surgery.

Authors:  Andrew J E Seely; Jelena Ivanovic; Jennifer Threader; Ahmed Al-Hussaini; Derar Al-Shehab; Tim Ramsay; Sebastian Gilbert; Donna E Maziak; Farid M Shamji; R Sudhir Sundaresan
Journal:  Ann Thorac Surg       Date:  2010-09       Impact factor: 4.330

5.  Surgical outcome measurement for a global patient population: validation of the Surgical Apgar Score in 8 countries.

Authors:  Alex B Haynes; Scott E Regenbogen; Thomas G Weiser; Stuart R Lipsitz; Gerald Dziekan; William R Berry; Atul A Gawande
Journal:  Surgery       Date:  2011-01-08       Impact factor: 3.982

Review 6.  Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis.

Authors:  K Kumagai; I Rouvelas; J A Tsai; D Mariosa; P A Lind; M Lindblad; W Ye; L Lundell; C Schuhmacher; M Mauer; B H Burmeister; J M Thomas; M Stahl; M Nilsson
Journal:  Eur J Surg Oncol       Date:  2014-11-27       Impact factor: 4.424

7.  External validation of a risk score in the prediction of the mortality after esophagectomy for cancer.

Authors:  X B D'Journo; J Berbis; J Jougon; P-Y Brichon; J Mouroux; O Tiffet; A Bernard; F de Dominicis; G Massard; P E Falcoz; P Thomas; M Dahan
Journal:  Dis Esophagus       Date:  2017-01-01       Impact factor: 3.429

8.  Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram.

Authors:  Sjoerd M Lagarde; Johannes B Reitsma; Anna-Karin D Maris; Mark I van Berge Henegouwen; Olivier R C Busch; Hugo Obertop; Aelko H Zwinderman; J Jan B van Lanschot
Journal:  Ann Thorac Surg       Date:  2008-06       Impact factor: 4.330

9.  The Surgical Apgar Score in esophagectomy.

Authors:  Christopher F Janowak; Justin D Blasberg; Lauren Taylor; James D Maloney; Ryan A Macke
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-10       Impact factor: 5.209

10.  Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model.

Authors:  Cameron D Wright; John C Kucharczuk; Sean M O'Brien; Joshua D Grab; Mark S Allen
Journal:  J Thorac Cardiovasc Surg       Date:  2009-03       Impact factor: 5.209

View more
  6 in total

1.  A low surgical Apgar score is a predictor of anastomotic leakage after transthoracic esophagectomy, but not a prognostic factor.

Authors:  Masato Hayashi; Hirofumi Kawakubo; Shuhei Mayanagi; Rieko Nakamura; Koichi Suda; Norihito Wada; Yuko Kitagawa
Journal:  Esophagus       Date:  2019-06-05       Impact factor: 4.230

Review 2.  The Reliability of Surgical Apgar Score in Predicting Immediate and Late Postoperative Morbidity and Mortality: A Narrative Review.

Authors:  Abhijit Nair; Aanchal Bharuka; Basanth Kumar Rayani
Journal:  Rambam Maimonides Med J       Date:  2018-01-29

3.  Comparison of short-term outcomes and three yearsurvival between total minimally invasive McKeown and dual-incision esophagectomy.

Authors:  Ju-Wei Mu; Shu-Geng Gao; Qi Xue; You-Sheng Mao; Da-Li Wang; Jun Zhao; Yu-Shun Gao; Jin-Feng Huang; Jie He
Journal:  Thorac Cancer       Date:  2017-01-04       Impact factor: 3.500

4.  Reduction of oxidative stress a key for enhanced postoperative recovery with fewer complications in esophageal surgery patients: Randomized control trial to investigate therapeutic impact of anesthesia management and usefulness of simple blood test for prediction of high-risk patients.

Authors:  Masahiko Tsuchiya; Kazumasa Shiomoto; Koh Mizutani; Kazuya Fujioka; Koichi Suehiro; Tokuhiro Yamada; Eisuke F Sato; Kiyonobu Nishikawa
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

5.  Predictive value of the surgical Apgar score on postoperative complications in advanced gastric cancer patients treated with neoadjuvant chemotherapy followed by radical gastrectomy: a single-center retrospective study.

Authors:  Masato Hayashi; Takaki Yoshikawa; Masahiro Yura; Sho Otsuki; Yukinori Yamagata; Shinji Morita; Hitoshi Katai; Toshirou Nishida
Journal:  BMC Surg       Date:  2020-07-11       Impact factor: 2.102

6.  Neoadjuvant therapy does not adversely affect the short-term outcome of critically ill cancer patients who underwent surgery.

Authors:  Xue-Zhong Xing; Hai-Jun Wang; Shi-Ning Qu; Chu-Lin Huang; Hao Wang; Zhen-Nan Yuan; Hao Zhang; Quan-Hui Yang
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.